Literature DB >> 18624669

Predictors of mortality from community-onset bloodstream infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.

Anucha Apisarnthanarak1, Pattarachai Kiratisin, Linda M Mundy.   

Abstract

In a cohort study of 36 patients with community-onset extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli or Klebsiella pneumoniae bloodstream infections, we found that predictors of mortality were community-onset infection with ESBL-producing K. pneumoniae pathogens (P = .02) and failure to receive an initial empirical regimen that included either beta-lactam and beta-lactamase-inhibitors or a carbapenem (P = .04).

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18624669     DOI: 10.1086/588082

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  14 in total

1.  Identifying patients harboring extended-spectrum-beta-lactamase-producing Enterobacteriaceae on hospital admission: derivation and validation of a scoring system.

Authors:  Mario Tumbarello; Enrico Maria Trecarichi; Matteo Bassetti; Francesco Giuseppe De Rosa; Teresa Spanu; Eugenia Di Meco; Angela Raffaella Losito; Andrea Parisini; Nicole Pagani; Roberto Cauda
Journal:  Antimicrob Agents Chemother       Date:  2011-05-02       Impact factor: 5.191

2.  Prevalence and risk factors for antibiotic-resistant community-associated bloodstream infections.

Authors:  Caitlin M Wolfe; Bevin Cohen; Elaine Larson
Journal:  J Infect Public Health       Date:  2014-03-13       Impact factor: 3.718

3.  Extended-spectrum β-lactamase-producing Escherichia coli strains in the feces of carriers contribute substantially to urinary tract infections in these patients.

Authors:  M Niki; I Hirai; A Yoshinaga; L Ulzii-Orshikh; A Nakata; A Yamamoto; M Yamamoto; Y Yamamoto
Journal:  Infection       Date:  2011-08-09       Impact factor: 3.553

4.  Clinical outcome of empiric antimicrobial therapy of bacteremia due to extended-spectrum beta-lactamase producing Escherichia coli and Klebsiella pneumoniae.

Authors:  Vikas P Chaubey; Johann Dd Pitout; Bruce Dalton; Terry Ross; Deirdre L Church; Daniel B Gregson; Kevin B Laupland
Journal:  BMC Res Notes       Date:  2010-04-27

5.  Clinical and Molecular Characterization of Community-Onset Urinary Tract Infections Due to Extended-Spectrum Cephalosporin-Resistant Enterobacteriaceae.

Authors:  Judith A Anesi; Ebbing Lautenbach; Irving Nachamkin; Charles Garrigan; Warren B Bilker; Mary Wheeler; Pam Tolomeo; Jennifer H Han
Journal:  Infect Control Hosp Epidemiol       Date:  2016-09-28       Impact factor: 3.254

6.  Poor clinical outcomes associated with community-onset urinary tract infections due to extended-spectrum cephalosporin-resistant Enterobacteriaceae.

Authors:  Judith A Anesi; Ebbing Lautenbach; Irving Nachamkin; Charles Garrigan; Warren B Bilker; Jacqueline Omorogbe; Lois Dankwa; Mary K Wheeler; Pam Tolomeo; Jennifer H Han
Journal:  Infect Control Hosp Epidemiol       Date:  2018-10-30       Impact factor: 3.254

Review 7.  Appropriate initial antibiotic therapy in hospitalized patients with gram-negative infections: systematic review and meta-analysis.

Authors:  Gowri Raman; Esther Avendano; Samantha Berger; Vandana Menon
Journal:  BMC Infect Dis       Date:  2015-09-30       Impact factor: 3.090

8.  Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli.

Authors:  Yu Bin Seo; Jacob Lee; Young Keun Kim; Seung Soon Lee; Jeong-A Lee; Hyo Youl Kim; Young Uh; Han-Sung Kim; Wonkeun Song
Journal:  BMC Infect Dis       Date:  2017-06-07       Impact factor: 3.090

9.  Febrile urinary-tract infection due to extended-spectrum beta-lactamase-producing Enterobacteriaceae in children: A French prospective multicenter study.

Authors:  Fouad Madhi; Camille Jung; Sandra Timsit; Corinne Levy; Sandra Biscardi; Mathie Lorrot; Emmanuel Grimprel; Laure Hees; Irina Craiu; Aurelien Galerne; François Dubos; Emmanuel Cixous; Véronique Hentgen; Stéphane Béchet; Stéphane Bonacorsi; Robert Cohen
Journal:  PLoS One       Date:  2018-01-25       Impact factor: 3.240

10.  Changing prevalence and antibiotic drug resistance pattern of pathogens seen in community-acquired pediatric urinary tract infections at a tertiary care hospital of North India.

Authors:  Vrushali Patwardhan; Dinesh Kumar; Varun Goel; Sarman Singh
Journal:  J Lab Physicians       Date:  2017 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.